http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ee30f86461d64378aaefbc2666c8d76
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Mauriac |
| name | Louis Mauriac |
| given-name | Louis |
| organization-name | From the Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute; Harvard School of Public Health; Frontier Science and Technology Research Foundation, Boston, MA; IBCSG Coordinating Center and Inselspital; Swiss Group for Clinical Cancer Research, Bern; Senology Center of Eastern Switzerland, Kantonsspital, St Gallen; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;... From the Division of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Division of Hematology and Medical Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL; Department of Medical Oncology, Institut Bergonié, Bordeaux; Department of Medical Oncology, CRLC Val d’ Aurelle-Paul Lamarque, Montpellier, France; Medical Oncology, Instituto National de Cancer, Rio de Janeiro; Departmento de Radiologia, Faculdade de... Department of Medical Oncology, Institut Bergonié, Institut Bergonié, Bordeaux, France From the Centro di Riferimento Oncologico, Aviano; Department of Medicine. European Institute of Oncology, Milan; National Cancer Research Institute, Genoa, Italy; International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute; Harvard School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA; IBCSG and University of Sydney, Sydney; Australian New Zealand Breast Cancer Trials Group, University of Newcastle, Calvary Mater Newcastle,... Institut Bergonié, Bordeaux, France. From the Baylor-Sammons Cancer Center, Dallas, and US Oncology, Houston, TX; Guy’s Hospital, London, United Kingdom; Petrov Research Institute, St Petersburg, Russia; Hopital Notre Dame, Montreal, and Ottawa Regional Cancer Centre, Ottawa, Canada; Issste Hospital, Mexico City, Mexico; Centre Rene Gauducheau Nantes-Atlantique, Saint Herblain, and Institut Bergonié, Bordeaux, France; Taipei-Veterans General Hospital, Taiwan; Beatson Oncology Centre, Glasgow, and Western General Hospital, Edinburgh,... From the International Breast Cancer Study Group (IBCSG); IBCSG Coordinating Center, Bern; Swiss Group for Clinical Cancer Research (SAKK), Senology Center of Eastern Switzerland, Kantonsspital, St Gallen; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; University of Sydney, Sydney; Australian New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle Mater Hospital, Newcastle, New South Wales; Box Hill and Maroondah Hospitals, Melbourne, Australia; IBCSG Statistical... From the Institut Curie; Hôtel Dieu, Paris; Centre René Gauducheau, Nantes; Centre Val d’Aurelle, Montpellier; Centre René Huguenin, Saint Cloud; Centre Antoine Lacassagne, Nice; Institut Bergonié, Bordeaux; Centre Léon Bérard, Lyon; Centre Eugène Marquis, Rennes; Centre Paul Papin, Angers; Centre Jean Perrin, Clermont-Ferrand, France; and the International Drug Development Institute, Brussels, Belgium. From the Duke University Comprehensive Cancer Center, Durham, NC; Lombardi Cancer Center, Washington DC; Institut Bergonié, Bordeaux Cedex, France; Instituto Valenciano de Oncologia, Valencia, Spain; Universitaets Frauen-und Poliklinik UKE, Hamburg, Germany; Breast Research Unit, Western General Hospital, Edinburgh, United Kingdom; Novartis Pharma AG, Basel, Switzerland; and Novartis Pharmaceuticals, East Hanover, NJ. 3Department of Pathology, Institut Bergonié, Bordeaux, France; and From the European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute; Harvard School of Public Health; Frontier Science and Technology Research Foundation; Harvard Medical School, Boston, MA; Breast Center, Kantonsspital, St Gallen; International Breast Cancer Study Group, Swiss Group for Clinical Cancer Research, Bern; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Danish Breast Cancer Cooperative Group,... From the Institut Claudius Regaud, Toulouse; Institut Bergonie, Bordeaux; Centre Eugene Marquis, Rennes; Centre Jean Perrin, Clermont-Ferrand, France; Centre Hospitalier de l'Université de Montréal–Hôpital Notre-Dame, Montreal, Quebec, Canada; Comitato Etico (Istituto di Ricovero e Cura a Carattere Scientifico) di Roma, IFO-Istituto Regina Elena, Rome, Italy; Dana-Farber Cancer Institute, Boston, MA; Albert Einstein Comprehensive Cancer Center, Montefiore Medical Center, Department of Oncology; Weill... From the Institut Gustave-Roussy, Villejuif; Institut Paoli Calmettes, Marseille; Institut Bergonié, Bordeaux; Centre Rene Huguenin, Saint-Cloud; Institut Curie, Paris, France; Regina Elena Cancer Institute, Rome; University Hospital, Modena, Italy; St Vincent’s Hospital, Fitzroy; Wesley Medical Centre, Auchenflour; Royal Melbourne Hospital, Melbourne, Australia; Nottingham City Hospital, Nottingham; Department of Oncology, Leicester Royal Infirmary, Leicester; Roche Products Limited, Welwyn Garden City,... Department of Medical Oncology, Institut Bergonié, Bordeaux, France Institut Bergonié, Bordeaux, France i Institut Bergonié, Bordeaux, France From the Fédération Nationale des Centres de Lutte Contre le Cancer, Paris, France. Department of Medical Oncology, Istitut Bergonié, Regional Cancer Center, Bordeaux, France. |
Incoming Links
Total number of triples: 79.